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Abstract
 
The guanine nucleotide exchange factor Vav1 regulates actin polymerization and contributes
to cytotoxicity by natural killer (NK) cells. An open question is how Vav1 becomes activated
and what receptor can signal upstream of actin cytoskeleton rearrangement upon NK cell
contact with target cells. Using transfected insect cells that express ligands of human NK cell
receptors, we show that engagement of the 
 
 
 
2 integrin LFA-1 on NK cells by intercellular
adhesion molecule (ICAM)-1 led to a tyrosine phosphorylation of Vav1 that was not sensitive
to cholesterol depletion and to inhibition of actin polymerization. Vav1 phosphorylation was
blocked by an inhibitor of Src-family kinases, and correlated with activation of its downstream
effector PAK. Binding of activation receptor 2B4 to its ligand CD48 was not sufficient for
Vav1 phosphorylation. However, coengagement of 2B4 with LFA-1 resulted in an enhance-
ment of Vav1 phosphorylation that was sensitive to cholesterol depletion and to inhibition of
actin polymerization. Vav1 was recruited to a detergent-resistant membrane (DRM) fraction
only when 2B4 and LFA-1 were coengaged, but not after LFA-1 engagement. Therefore,
binding of LFA-1 to ICAM-1 on target cells may initiate an early signaling cascade in NK cells
through activation of Vav1, leading to cytoskeleton reorganization and amplification of signals
from other activation receptors.
Key words: natural killer cell • lipid raft • LFA-1 • Vav1 • 2B4
 
Introduction
 
Target cell lysis by NK cells is activated by a number of re-
ceptors that bind to ligands expressed on tumor cells and
virus-infected cells. Several NK cell receptors signal for
cytotoxicity through their association with partner chains
that carry immunoreceptor tyrosine-based activation mo-
tifs (ITAM) in their cytoplasmic tails, such as DAP12 and
the Fc receptor 
 
 
 
 chain (1). The activation receptor
NKG2D signals through its association with DAP10,
which carries a YxxM cytoplasmic tyrosine motif, and, at
least in the mouse, with the ITAM-containing DAP12
(2–4). However, neither ITAM-mediated signals nor
NKG2D are necessary to induce natural cytotoxicity, as
demonstrated with mouse NK cells deficient in both Syk
and ZAP70 tyrosine kinases, and with target cells lacking
NKG2D ligands (5). Other receptors that contribute to
natural cytotoxicity include the 
 
 
 
2 integrin LFA-1 (6),
which is essential for adhesion to target cells, and a
number of costimulatory receptors, such as CD2, 2B4
(CD244), and CD44 (7, 8).
In T cells, the initial signals that lead to enhanced adhe-
sion through LFA-1, actin cytoskeleton rearrangement, and
receptor clustering at the cellular interface upon contact
with an APC are delivered by TCR engagement (9). The
guanine nucleotide exchange factor (GEF) domain-con-
taining Vav1, through activation of the small GTPases
Rac1 and Cdc42, is an essential mediator of the TCR-
induced cytoskeleton reorganization and polarization of
cholesterol-rich lipid rafts (10–12). The GEF activity of
Vav1 is enhanced by phosphorylation of several tyrosines in
Vav1 (13). Vav1 and Rac1 both contribute to target cell ly-
sis by NK cells (14–17), but the receptors and early signals
that activate Vav1 are not known. NK cells rapidly form
tight conjugates with cells expressing ICAM-1, through
engagement of the 
 
 
 
2 integrin LFA-1 (18). To test for the
outcome of LFA-1 engagement by its natural ligand, and to
avoid the multiple receptor–ligand interactions that occur
between NK cells and mammalian target cells, we have
transfected insect cells with ICAM-1, in combination with
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other ligands of human NK cell receptors (18). Transfected
insect cells have been used successfully to define the mini-
mal requirements for T cell activation (19). Here we show
that contact of NK cells with insect cells expressing
ICAM-1 alone resulted in a tyrosine phosphorylation of
Vav1 that was not dependent on actin polymerization and
on lipid rafts. In contrast, Vav1 phosphorylation induced
by coengagement of 2B4 with LFA-1 was dependent on
actin polymerization and on lipid rafts. Therefore, LFA-1
has the properties required of an early activation receptor
on NK cells.
 
Materials and Methods
 
Antibodies and Cells.
 
For Western blot analysis, the following
Abs were used: biotin-conjugated anti-phosphotyrosine (clone
PY-20; Transduction Laboratories), mouse anti-Vav1 (Upstate),
and anti-CD45 (Transduction Laboratories). For blocking exper-
iments, anti-CD11a (clone TS1/22; Endogen) and anti-CD11b
Abs (clone LM2/1; Biosource International) were used. The rab-
bit polyclonal antibodies H-211 to Vav1 and C-19 to PAK (Santa
Cruz Biotechnology, Inc.) were used for immunoprecipitations.
For cross-linking experiments we used the anti CD11a (BD Bio-
sciences) and F(ab
 
 
 
)
 
2
 
 goat anti–mouse IgG (Jackson ImmunoRe-
search Laboratories). Human polyclonal NK cells were isolated
from PBL using the MACS NK cell isolation kit (Miltenyi Bio-
tech). NK cells and transfected Drosophila Schneider 2 (SC2)
were obtained and maintained in culture as described (18).
 
Receptor Cross-Linking.
 
For antibody-mediated cross-linking
of CD11a, 3 
 
 
 
 10
 
7
 
 polyclonal NK cells were incubated with 5
 
 
 
g of anti CD11a Ab for 15 min at 4
 
 
 
C. Cells were washed once
with Iscove’s medium and 50 
 
 
 
g/ml of F(ab
 
 
 
)
 
2
 
 goat anti–mouse
were added. Cells were washed again and cross-linking was per-
formed for the indicated times at 37
 
 
 
C. Cells were centrifuged
and lysed before Western blot analysis.
 
Cell Mixing.
 
NK and target cells were mixed at an effector to
target ratio of 6:1, briefly centrifuged, and allowed to recover for
20 min at room temperature before incubation at 37
 
 
 
C for 20
min. Cells were then lysed in ice-cold lysis buffer (1% Triton
X-100, 50 mM NaCl, 10 mM EDTA, 50 mM NaFluoride, 10
mM NaPhosphate, 1 mM NaVO
 
4
 
, PMSF). For detergent-resis-
tant membrane (DRM) experiments, cell mixing of 3 
 
 
 
 10
 
8
 
polyclonal human NK cells were mixed with 0.5 
 
 
 
 10
 
8
 
 SC2
transfectants, as described above.
 
In Vitro Kinase Assay.
 
NK and target cells were mixed at a ra-
tio of 6:1 and allowed to recover for 10 min at room temperature
before incubation at 37
 
 
 
C for 5 min. Cells were then lysed in 1%
NP-40, 140 mM NaCl, 1 mM EDTA, 10 mM Tris-HCl, pH 8, 1
mM NaVO
 
4
 
, and PMSF. Lysates were centrifuged at 14,000 
 
g
 
 for
20 min and precleared with a control Ab for 1 h, followed by im-
munoprecipitation with polyclonal anti-PAK. Immunoprecipi-
tated proteins were washed 3 times in lysis buffer and incubated
with 10 
 
 
 
Ci of [
 
 
 
-
 
32
 
P] ATP in 30 mM Tris, 20 mM MgCl
 
2
 
, 2
mM MnCl
 
2
 
, 10 
 
 
 
M ATP, and 5 
 
 
 
g myelin basic protein (MBP;
Sigma-Aldrich) for 30 min at 30
 
 
 
C. Sample buffer was added and
the mixture was electrophoresed on a 14% SDS gel. After drying,
 
32
 
P-labeled MBP was detected by autoradiography.
 
Blocking Experiments.
 
For antibody blocking experiments,
NK cells were preincubated with 10 
 
 
 
g/ml of purified CD11a or
CD11b mAb for 30 min at 4
 
 
 
C, and washed once before cell
mixing. For inhibition of tyrosine kinases and of actin polymer-
ization, NK cells were preincubated for 40 min at 37
 
 
 
C with 30
 
 
 
M PP1, 12 
 
 
 
M Piceatannol, 20 
 
 
 
M cytochalasin D (BIOMOL
Research Laboratories, Inc.), or 20 
 
 
 
M Latrunculin A (Molecular
Probes) and used in mixing experiments in the presence of the in-
hibitors. For cholesterol depletion, NK cells were washed in PBS,
incubated 30 min at 37
 
 
 
C with 12.5 mM methyl-
 
 
 
-Cyclodextrin
(MCD; Sigma-Aldrich), and washed again before cell mixing ex-
periments.
 
Immunoprecipitation and Western Blot Analysis.
 
Cells were
lysed in ice-cold lysis buffer. Lysates were centrifuged at 12,000 
 
g
 
for 20 min and supernatants were precleared with protein G for
1 h. Specific immunoprecipitation was performed overnight at 4
 
 
 
C.
Total proteins or immunoprecipitated proteins were separated by
SDS-PAGE. The gels were blotted onto PVDF membranes (Im-
mobilon P; Millipore). Membranes were then blocked 30 min
with 5% BSA in PBS 0.1% Tween-20 and incubated overnight
with the specific Ab at 4
 
 
 
C. After washing, the membranes were
incubated with streptavidin-horseradish peroxidase-conjugate
(Amersham Biosciences) or goat anti–mouse IgG peroxidase
(Jackson ImmunoResearch Laboratories), washed, stained with
enhanced chemiluminescence reagent (Pierce Chemical Co.),
and exposed to X-ray film.
 
Isolation of DRM.
 
DRMs were isolated by ultracentrifugation
in a sucrose gradient as described (20) except that cells were lysed
in a buffer containing 10 mM Tris-HCl, pH 7.4, 150 mM NaCl,
5 mM EDTA, and 0.5% Triton X-100. The fractions containing
DRM were identified by Western blotting with peroxidase-con-
jugated Cholera Toxin B-subunit (Sigma-Aldrich).
 
Results and Discussion
 
Engagement of LFA-1 on Human NK Cells Induces Tyrosine
Phosphorylation of Vav1.
 
To investigate the signals deliv-
ered by LFA-1 alone, a mAb specific for CD11a was used
to cross-link LFA-1 on polyclonal NK cells. Western blot-
ting of cell lysates with the anti-phosphotyrosine mAb PY-
20 revealed tyrosine-phosphorylated proteins specifically
induced by LFA-1 cross-linking for 1, 5, and 10 min (Fig.
1 A). No tyrosine phosphorylation occurred by cross-link-
ing CD56 on NK cells (unpublished data). One of the
prominent tyrosine phosphorylated proteins was similar in
size to Vav1, as shown by reprobing the membrane with an
anti-Vav1 Ab (Fig. 1 A). Immunoprecipitations with a rab-
bit anti-Vav1 Ab and blotting for tyrosine phosphorylation
showed that Vav1 was phosphorylated after 5 and 10 min
of CD11a cross-linking (Fig. 1 B). No phosphorylated
Vav1 was detected after CD56 cross-linking (unpublished
data). These results are similar to the Vav1 phosphorylation
detected in neutrophils after cross-linking 
 
 
 
2 integrin with
mAb (21), as well as Vav1 phosphorylation in NK cells af-
ter cross-linking 
 
 
 
1 integrin with mAb (22). Secretion of
TNF
 
 
 
 by NK cells upon cross-linking of LFA-1 by mAb,
even in the absence of cell aggregation, suggested also a sig-
naling function of LFA-1 (23).
To test the outcome of LFA-1 engagement in a more
physiological context, NK cells were mixed with the 
 
Dro-
sophila
 
 SC2 cell line expressing human ICAM-1 (SC2-
ICAM). Phospho-Vav1 was detected in NK cells mixed
with SC2-ICAM, but not with SC2 cells, after immuno-
precipitation of Vav1 and blotting with anti-phosphoty-
rosine mAb PY-20 (Fig. 2 A). Experiments with unmixedT
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SC2 and SC2-ICAM cells confirmed that anti-Vav1 anti-
body did not precipitate nonspecific bands from SC2 cells
(unpublished data). NK cells express the two 
 
 
 
2 integrins
LFA-1 and Mac-1. Blocking experiments with Abs to
CD11a (LFA-1) and CD11b (Mac-1) showed that Vav1
phosphorylation was induced mainly by LFA-1 (Fig. 2 A).
We therefore conclude that ICAM-1, expressed on SC2
cells, induces Vav1 phosphorylation in NK cells mostly
through interaction with LFA-1.
To test if the phosphorylation of Vav1 was accompanied
by enhanced GEF activity, the kinase activity of PAK, a
downstream effector of Vav1-Rac1 signals, was measured
after mixing NK cells with SC2 cells. Increased PAK activ-
ity in NK cells was detected after mixing with SC2-ICAM
cells for 5 min (Fig. 2 B). Vav1 phosphorylation in the
same cells was also detected (Fig. 2 B). Whereas Vav1
phosphorylation increased between 5 and 20 min, PAK ac-
tivity decreased (unpublished data), indicating a complex
regulation of this signaling pathway. The GEF activity of
Vav1 is enhanced by phosphorylation through Src-family
kinases (13), and Vav1 phosphorylation during antigen-
specific activation of T cells requires Fyn (24). On the
other hand, ligation of 
 
 
 
2 integrin on neutrophils activates
the tyrosine kinase Syk, which is required for neutrophil
activation (25), and attachment to fibrinogen of CHO cells
expressing 
 
 
 
3 integrin results in a Syk-dependent Vav1
phosphorylation (26). We therefore tested if Vav1 phos-
phorylation induced by LFA-1 in NK cells required a Src-
family kinase, a Syk/ZAP70 kinase, or both. Treatment of
NK cells with PP1, an inhibitor of src-family kinases, but
not with Piceatannol, an inhibitor of the Syk/ZAP70 ki-
nases, blocked the Vav1 phosphorylation induced by SC2-
ICAM cells (Fig. 2 C). In parallel, phosphorylation of re-
ceptor 2B4 was monitored after incubation of the same
NK cells with a human target cell expressing the 2B4
ligand CD48. As reported previously (27), phosphorylation
of 2B4 was completely inhibited by PP1 and was greatly
reduced by Piceatannol (unpublished data). These results
indicate that Src-family kinase activity but not Syk or
ZAP70 is required for the LFA-1–induced phosphoryla-
tion of Vav1.
Vav1 phosphorylation was measured after incubation of
NK cells with SC2 cells expressing ICAM-1, CD48 (SC2-
CD48), or coexpressing both (SC2-ICAM-CD48). Cell
sorting was used to obtain matched levels of ICAM-1 ex-
pressed on SC2-ICAM and SC2-ICAM-CD48 cells, and
of CD48 on SC2-CD48 and SC2-ICAM-CD48 cells (18).
Vav1 phosphorylation was not detectable after mixing with
SC2-CD48 cells (Fig. 3 A). This result is not simply due to
a lack of 2B4 signaling because strong tyrosine phosphory-
lation of 2B4 occurs after mixing with SC2-CD48 cells
(unpublished data). On the other hand, coengagement of
LFA-1 and 2B4 led to an increase in Vav1 phosphoryla-
tion, as compared with that obtained by engagement of
LFA-1 alone (Fig. 3 A). Therefore, signals through LFA-1
but not 2B4 lead to a phosphorylation of Vav1 which can
be enhanced by 2B4 signals. The possibility that another
receptor on NK cells binds to something on insect cells
cannot be excluded. However, if such a receptor were to
Figure 1. Tyrosine phosphorylation of Vav1 after antibody-induced
engagement of LFA-1 in NK cells. LFA-1 on NK cells was cross-linked
with anti-CD11a and a F(ab )2 goat anti–mouse antibody for the indi-
cated times at 37 C. (A) Cell lysates were resolved by 4–20% SDS-PAGE
and immunoblotted with biotinylated anti phosphotyrosine Ab, PY-20
(p-Tyr, left). (B) Vav1 was immunoprecipitated from cell lysates, sepa-
rated on 6% SDS-PAGE, and blotted with PY-20 mAb (p-Tyr, left). The
same blots were reprobed with an anti-Vav1 Ab (Vav1, right). Figure 2. Phosphorylation of Vav1 induced by engagement of LFA-1
on NK cells. (A) NK cells, pretreated with anti-CD11b or anti-CD11a,
were mixed with SC2 or SC2-ICAM-1 target cells. Vav1 was immuno-
precipitated from cell lysates, resolved on a 6% SDS-PAGE, and blotted
with biotinylated anti phosphotyrosine Ab PY-20 (p-Tyr). The same blot
was reblotted with an anti-Vav1 Ab (Vav1). (B) PAK kinase activity in
NK cells mixed with SC2 and SC2-ICAM cells. PAK or control (rabbit
IgG) immunoprecipitates were subjected to an in vitro kinase assay.
Phosphorylation of the MBP substrate (p-MBP) was detected by autora-
diography. Vav1 was immunoprecipitated from the supernatant of the
PAK immunoprecipitation, and tested for tyrosine phosphorylation as in
(A). (C) Inhibition of Vav1 tyrosine phosphorylation. Vav1 phosphoryla-
tion was tested in NK cells either untreated ( ), treated with PP1, or
treated with Piceatannol (Pic), after mixing with SC2 and SC2-ICAM
cells, as indicated.T
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exist it is not sufficient to induce Vav1 phosphorylation,
nor can it enhance the LFA-1–induced Vav1 phosphoryla-
tion as well as 2B4 does.
 
Role of Actin Cytoskeleton and of Lipid Rafts in Vav1 Phos-
phorylation.
 
Work in T cells has demonstrated that actin
cytoskeleton rearrangement and lipid raft polarization in-
duced by contact with an APC are dependent on Vav1 ac-
tivity (10–12). Therefore, early signals upstream of actin
polymerization that induce Vav1 phosphorylation must ex-
ist. Activation receptor 2B4 on NK cells is not likely to
provide such early signals because 2B4 phosphorylation is
itself dependent on actin polymerization (20). To test if
LFA-1 engagement on NK cells can activate Vav1 up-
stream of cytoskeleton rearrangements, actin polymeriza-
tion was blocked by treatment with cytochalasin D and La-
trunculin A. As shown in Fig. 3 B, these inhibitors did not
block the Vav1 phosphorylation induced by SC2-ICAM
cells. In contrast, and consistent with the actin polymeriza-
tion-dependent phosphorylation of 2B4 (20), the enhance-
ment of Vav1 phosphorylation due to coengagement of
2B4 with LFA-1 was blocked by cytochalasin D and La-
trunculin A (Fig. 3 B). These results show that these inhib-
itors were effective in blocking the 2B4 signal leading to
enhanced Vav1 phosphorylation, but not the LFA-1 signal.
Cholesterol-rich membrane domains, referred to as lipid
rafts or DRM domains, contribute to cytotoxicity of NK
cells, and lipid raft clustering at the NK-target cell contact
correlates with target cell lysis (28). Furthermore, phos-
phorylation of 2B4 and 2B4-mediated NK cell activation
are sensitive to cholesterol depletion, and phosphorylated
2B4 is found exclusively in DRM domains (20). Choles-
terol was depleted from NK cell membranes by treatment
with MCD in order to test whether Vav1 phosphorylation
induced by LFA-1 required lipid rafts. Cholesterol deple-
tion did not block Vav1 phosphorylation induced by LFA-1,
but did prevent the 2B4-induced enhancement in Vav1
phosphorylation (Fig. 3 C). These results show that en-
gagement of LFA-1 by its natural ligand on target cells leads
to Vav1 tyrosine phosphorylation without a requirement
for actin polymerization or lipid rafts. Therefore, signals
upstream of actin polymerization and lipid raft clustering
induce Vav1 phosphorylation, which is then enhanced by
Figure 3. Phosphorylation of Vav1 induced by engagement of LFA-1
and of 2B4 on NK cells. (A) NK cells were mixed with SC2 ( ),
SC2-CD48 (CD48), SC2-ICAM-1 (ICAM), or SC2-ICAM-CD48
(ICAM CD48) target cells. Vav1 was immunoprecipitated, resolved on
a 6% SDS-PAGE, and blotted with biotinylated-PY-20 (p-Tyr, left). The
same blot was reblotted with an anti-Vav1 Ab (Vav1). (B and C) Vav1
phosphorylation induced by LFA-1 is independent of actin polymeriza-
tion and of lipid rafts. NK cells treated with cytochalasin D (Cyt.D) and
Latrunculin A (B), or with MCD (C) were mixed with SC2 ( ), SC2-
ICAM (ICAM), or SC2-ICAM-CD48 (ICAM CD48) cells. Vav1
phosphorylation was detected as in (A).
Figure 4. Vav1 phosphorylation and translocation into DRM fractions.
(A) DRM domains of polyclonal NK cells were characterized by Western
blot analysis. Blots were probed with cholera toxin B subunit (CtxB) and
anti-CD45 Ab (CD45). Vav1 immunoprecipitated from gradient fractions
2–12 was Western blotted with anti-Vav1 Ab (Vav1). (B) NK cells that
were pretreated with ( ) or without ( ) cytochalasin D (Cyt D), were
mixed with SC2 ( ), SC2-ICAM (ICAM), or SC2- ICAM-CD48
(ICAM CD48) cells. Cells were lysed, and DRM isolated using sucrose
gradient ultracentrifugation. Fractions 3, 4, and 5 were pooled and corre-
spond to the DRM fractions (DRM), whereas pooled fractions 10, 11, and
12 correspond to the soluble fraction (soluble). Lysates of each pool were
analyzed by Western blot with cholera toxin B subunit (CtxB) and anti-
CD45 (CD45) Ab. Immunoprecipitated Vav1 was detected by Western
blot with anti Vav1 Ab (Vav1). Phospho-Vav1 was detected by blotting
the same membrane with an anti-phosphotyrosine Ab, PY-20 (p-Tyr).T
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downstream signals. Similarly, in T cells activated by TCR
engagement a first wave of Vav1 tyrosine phosphorylation
independent of lipid rafts was detected, whereas a second
wave of Vav1 phosphorylation occurred after raft coales-
cence and F-actin reorganization (29). In addition, once it
is activated, LFA-1 on T cells induces actin polymerization
upon binding to ICAM-1 (30).
The recruitment of Vav1 into DRM domains was evalu-
ated. The separation of DRM from soluble membrane
fractions by sucrose gradient ultracentrifugation was moni-
tored by blotting gradient fractions with Cholera Toxin
subunit B, which binds to the DRM-resident ganglioside
GM1, and for CD45, which resides in the soluble fraction
(Fig. 4 A). In nonstimulated NK cells, Vav1 was present
exclusively in the detergent-soluble fractions (Fig. 4 A).
DRM and soluble membrane domains were isolated from
NK cells mixed with SC2, SC2-ICAM, and SC2-ICAM-
CD48 cells (Fig. 4 B). Immunoprecipitated Vav1 was
probed by Western blot with an anti-phosphotyrosine
mAb and with an anti-Vav1 mAb. The results with NK
cells mixed with SC2-ICAM cells confirmed the actin po-
lymerization-independent phosphorylation of Vav1 and
showed that phospho-Vav1 remained in the soluble frac-
tion (Fig. 4 B). The actin polymerization-dependent en-
hancement of Vav1 phosphorylation in NK cells mixed
with SC2-ICAM-CD48 cells was confirmed (Fig. 4 B). In
addition, Vav1 translocation into DRM was detected, and
DRM-associated Vav1 was phosphorylated. Movement of
Vav1 to DRM was sensitive to cytochalasin D (Fig. 4 B).
Therefore, recruitment of Vav1 to lipid rafts requires sig-
nals that are downstream of actin polymerization.
 
Conclusions.
 
Our results show that engagement of
LFA-1 by ICAM-1 on target cells leads to a tyrosine phos-
phorylation of Vav1 that occurs upstream of actin polymer-
ization and of lipid raft clustering. Thus, LFA-1 may pro-
vide an essential early signal to NK cells upon contact with
ICAM-expressing target cells, which leads to downstream
signals via Vav1 that are required for further receptor clus-
tering. The LFA-1 signal is most likely relevant to NK cell
effector function, as NK cells lysed insect cells expressing
ICAM-1 (unpublished data). We propose the following
model for the regulation of NK cell cytotoxicity. Upon
contact with ICAM-expressing target cells, NK cells ad-
here rapidly through engagement of LFA-1 (18). In addi-
tion to its role in adhesion, LFA-1 delivers activation sig-
nals that result in tyrosine phosphorylation of Vav1 by a
Src-family kinase, and Rac1 activation. Cytoskeletal rear-
rangements induce clustering and phosphorylation of acti-
vation receptors, such as 2B4, in lipid rafts (20). In turn,
2B4 contributes additional signals for the activation of cy-
totoxicity, including Vav1 translocation into lipid rafts, and
enhanced Vav1 phosphorylation. The actin polymeriza-
tion- and lipid raft-dependent 2B4 signaling provides a
point at which NK cell cytotoxicity can be controlled. In-
deed, coengagement of MHC class I–specific inhibitory re-
ceptors on NK cells blocks the recruitment of 2B4 into
lipid rafts, thereby preventing NK cell activation at an early
step (20).
Binding of LFA-1 to ICAM-1 on insect cells induces
signals that lead to cytotoxicity by NK cells. 
 
 
 
2 integrin
binding to ICAM-1 induces degranulation by activated
neutrophils (25). In contrast to T cells, which rely on the
TCR to initiate activation signals and up-regulate LFA-1–
mediated adhesion, innate cells such as NK cells and neu-
trophils use LFA-1 directly to transmit activation signals.
 
We gratefully acknowledge Y. Bryceson, S. Rajagopalan, and C.
Watzl for help in NK cell isolation, as well as M. Faure, C. Watzl,
A. Cherukuri, and S. Pierce for helpful discussions.
 
Note added in proof:
 
 Consistent with the model proposed here for
the regulation of NK cell cytotoxicity, phosphorylated Vav1 in NK
cells is a specific substrate of tyrosine phosphatase SHP-1 during in-
hibition mediated by binding of inhibitory receptor to MHC class I
on target cells (31).
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